ROIV
Roivant Sciences Ltd.
$27.76
-$0.57(-2.01%)
45
Overall
--
Value
45
Tech
--
Quality
Market Cap
$19.82B
Volume
2.93M
52W Range
$8.73 - $30.33
Target Price
$33.25
Latest News for ROIV
Roivant Advances Brepocitinib Program, Refocuses Autoimmune Portfolio
TipRanks Auto-Generated Newsdesk•4 days ago•Apr 02, 2026
Roivant Sciences ( ($ROIV) ) has provided an update. On April 2, 2026, Roivant announced that its subsidiary Priovant had launched a seamless Phase......
Roivant Sciences (ROIV) Gets a Buy from H.C. Wainwright
TipRanks Auto-Generated Intelligence Newsdesk•a month ago•Mar 09, 2026
H.C. Wainwright analyst Douglas Tsao maintained a Buy rating on Roivant Sciences yesterday and set a price target of $34.00. According to TipRanks,......
News data is sourced from MarketXLS API and updated regularly.
Showing 2 of 2 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ROIV | $27.76 | -2.0% | 2.93M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |